Skip to content

Author

Shi-Heng Wang

We have 3 of 29 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Self-reported and recent claims-based major depressive disorder identifies distinct risk profiles in a nationwide population study.

BACKGROUND Major depressive disorder (MDD) in population studies is commonly identified from self-reported history or healthcare records, but agreement is often modest and the implications of discordance remain unclear. METHODS We included 135,287 Taiwan Biobank participants enrolled from 2008 to 2020 whose baseline...

Chi-Shin Wu, Kuei-Yu Chen, Pei-Qi Chen et al. · 0 citations
Open access Sep 2026

Employment trajectories following the diagnosis and after long-acting injectable antipsychotic treatment in patients with schizophrenia: A nationwide study.

OBJECTIVE This study examined employment trajectories following the diagnosis and antipsychotic treatment of schizophrenia, with particular focus on transitions to long-acting injectable antipsychotic treatment. METHODS We conducted a nationwide matched cohort study using Taiwan's National Health Insurance Research D...

Chi-Shin Wu, Shi-Heng Wang, Wei-Lieh Huang et al. · 0 citations
Sep 2026

Paternal Valproate Exposure and Offspring Neurodevelopmental Outcomes.

A large population-based study in Asia found no increased risk of NDDs in offspring following paternal exposure to valproate or other ASMs, which may contribute to ongoing debates about the management of valproate in men of reproductive age.

Y. A. Feng, Mei-Chen Lin, Ching-Hsuan Tseng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.